Ultimately, AOD-9604 stands out as a specialized fat-loss peptide, but its effectiveness and long-term impact require further research before it can be widely recommended for clinical use
Jos Carlos Mndez: nothing to disclose
Practical Implementation Strategies Clinic-Level Interventions Electronic health record modifications can systematically prompt providers to assess endometriosis-related symptoms in appropriate patient populations
Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P645 - ESOC25-1785 INTRAVENOUS THROMBOLYSIS BEFORE ENDOVASCULAR TREATMENT IN ACUTE VERTEBROBASILAR OCCLUSIONS: A POOLED ANALYSIS OF THE FRENCH AND GERMAN NATIONAL STROKE REGISTRIES Raoul Pop 1 , Stefanos Finitsis 2 , Bertrand Lapergue 3 , Marek Sykora 4 , Daniel Strbian *5 , Joshua Mbroh 6 , Xinchen Hui 6 , Florian Hennersdorf 7 , Ulrike Ernemann 7 , Sven Poli 6 , Benjamin Gory 8 1 University Hospitals Strasbourg, Strasbourg, France, 2 4Ahepa Hospital, Aristotle University of Thessaloniki, Greece, Thessaloniki, Greece, 3 Department of Neurology, Foch Hospital, Versailles Saint-Quentin en Yvelines University, Suresnes, France, Paris, France, 4 6Department of Neurology, St
"Cyanocobalamin Injection"
The peptide exists in two primary variants that differ in their duration of action
